A61P 27 - Drugs for disorders of the senses

Patents for A61P 27 - Drugs for disorders of the senses (53,017)
12/1997
12/29/1997	EP0665744B1 Stable extended release oral dosage composition
12/24/1997	WO1997048418A1 Improved method for treatment and diagnosis of il-5 mediated disorders
12/24/1997	WO1997042941A3 Buccal delivery system
12/24/1997	CN1168697A Rantes peptide and fragments and compositions comprising it for treatment of inflammation
12/24/1997	CN1168678A Method of treating diabetes mellitus using KGF
12/24/1997	CN1168672A 2,7-substituierte octahydro-1H-pyrido £1,2-A\| pyrazin derivate
12/24/1997	CN1168277A Eyesight granule and its compounding process
12/24/1997	CA2258515A1 Improved method for treatment and diagnosis of il-5 mediated disorders
12/23/1997	US5700838 Hydroxamic acid derivatives as metalloproteinase inhibitors
12/23/1997	US5700827 Amino acid derivatives, processes for the manufacture thereof and pharmaceutical compositions (II) containing these compounds
12/23/1997	US5700816 Antiarthritic agents
12/23/1997	CA2084663C Non-hygroscopic mono-ammonium salts
12/18/1997	WO1997031895A3 Cyclopentane heptan(ene)oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents
12/17/1997	EP0812592A1 An agent for the prevention or treatment of cataracts
12/17/1997	EP0812198A1 Storage-stable prostaglandin compositions
12/17/1997	EP0812190A1 R-enantiomer of n-propargyl-1-aminoindan, salts, compositions and uses thereof
12/17/1997	EP0607332B1 Method of prophylaxis or treatment of antigen presenting cell driven skin conditions using inhibitors of the cd2/lfa-3 interaction
12/16/1997	US5698706 Heterocyclic amides and methods of use
12/16/1997	US5698533 Mixing warm water with a hydrocarbonaceous semi-solid or oil containing a drug, atomizing and applying to the eye in the form of liquid drops; eliminates the need for chloroflurocarbon propellants
12/16/1997	US5698232 Pharmaceutical composition for treatment of sudden deafness
12/16/1997	US5698219 Nanoemulsion of the oil water type, useful as an ophthalmic vehicle and process for the preparation thereof
12/11/1997	WO1997046671A1 Enhanced efficacy of liposomal antisense delivery
12/11/1997	WO1997046579A1 Neuropeptide y agonists
12/11/1997	CA2257424A1 Neuropeptide y agonists
12/11/1997	CA2256456A1 Enhanced efficacy of liposomal antisense delivery
12/10/1997	EP0811374A1 Combination dosage form comprising cetirizine and pseudoephedrine
12/10/1997	EP0810875A1 Multifunctional enzyme
12/10/1997	EP0810864A1 2,6-diaryl pyridazinones with immunosuppressant activity
12/09/1997	US5696166 Administering in topical ophthalmic formulation
12/09/1997	US5696141 Isoxazoline compounds as 5-lipoxygenase inhibitors
12/09/1997	US5696123 Neurokinin antagonists
12/09/1997	US5696091 Use of growth factor and antimetabolite combination to prevent or retard secondary cataract formation
12/09/1997	US5696076 5-lipoxygenase-activating protein II
12/09/1997	CA1339573C Pyrimido¬4,5-d\| pyrimidine derivatives for use as bronchodilators
12/04/1997	WO1997045447A1 METHODS AND COMPOSITIONS USEFUL FOR INHIBITION OF αvβ5 MEDIATED ANGIOGENESIS
12/04/1997	WO1997045417A1 Cytokine production inhibitors, formulations thereof and their use in medicine, and methods for their identification
12/04/1997	WO1997045407A1 Novel anandamide amidase inhibitors as analgesic agents
12/04/1997	WO1997045405A1 Cyclopentan(en)oic acid, 2-alkenyl derivatives as therapeutic agents in the treatment of ocular hypertension
12/04/1997	WO1997045402A1 Phenylsulfonamide derivatives
12/04/1997	WO1997045400A1 Phenyl derivatives containing an acidic group, their preparation and their use as chloride channel blockers
12/04/1997	WO1997045137A1 Methods and compositions useful for inhibition of angiogenesis
12/04/1997	WO1997045135A1 Stable pharmaceutical composition of bdnf
12/04/1997	WO1997045111A1 Phenyl derivatives useful as blockers of chloride channels
12/04/1997	WO1997045105A1 Compositions and methods for treating or preventing diseases of body passageways
12/04/1997	CA2256588A1 Methods and compositions useful for inhibition of .alpha.v.beta.5 mediated angiogenesis
12/04/1997	CA2256404A1 Cyclopentan(en)oic acid, 2-alkenyl derivatives as therapeutic agents in the treatment of ocular hypertension
12/04/1997	CA2227811A1 Cytokine production inhibitors, formulations thereof and their use in medicine, and methods for their identification
12/03/1997	EP0809636A1 Substituted isoxazoles for the treatment of inflammation
12/03/1997	EP0809635A1 Alpha-substituted hydrazides having calpain inhibitory activity
12/03/1997	EP0809630A1 Indole derivatives with affinity for the cannabinoid receptor
12/03/1997	EP0809511A1 Inhibition of angiogenesis using interleukin-12
12/03/1997	CN1166825A Metalloproteinase inhibitors
12/03/1997	CN1166353A Oral medicine pill for curing myopia and amblyopia
12/02/1997	US5693844 2-cyano-3-hydroxy-propenamides
12/02/1997	US5693775 Fibroblast growth factor homologous factor-1 (FHF-1) and methods of use
12/02/1997	US5693654 Medicaments for treating intraocular pressure
12/02/1997	US5693633 Angiotensin II antagonists
12/02/1997	US5693607 Administering to treat fibroproliferative disorders
11/1997
11/27/1997	WO1997044053A1 Pharmaceutical compositions containing cyclosporine and a carrier comprising at least an ester of alpha-glycerophosphoric acid
11/27/1997	WO1997038665A3 Inhibitors of farnesyl-protein transferase
11/27/1997	CA2255640A1 Pharmaceutical compositions containing cyclosporine and a carrier comprising at least an ester of alpha-glycerophosphoric acid
11/26/1997	EP0808163A2 Use of thiazolium compounds for preventing and reversing the formation of advanced glycosylation endproducts
11/26/1997	EP0808160A1 Deprenyl compounds for treatment of glaucoma
11/25/1997	US5691381 Antagonist of tumor necrosis factor, antiinflammatory agent, antiarthritic agent
11/25/1997	US5691379 Dihydrolipoic acid as an ophthalmological agent to suppress intolerance reactions in the area between implants and living body tissue
11/25/1997	US5691370 5-(2-imidazolinylamino)benzimidazole compounds useful as alpha-2-adrenoceptor agonists
11/25/1997	US5691347 Angiotensin ii inhibitors and vasoconstriction
11/25/1997	US5691167 DNA encoding allergenic proteins and peptides from Johnson grass pollen
11/20/1997	WO1997043304A1 Novel compounds
11/20/1997	WO1997043303A1 Novel compounds
11/20/1997	WO1997043276A1 Novel 2,3 disubstituted-4(3h)-quinazolinones
11/20/1997	WO1997043272A2 Benzofurans and benzopyrans as chronobiological agents
11/20/1997	WO1997043247A1 Inhibition of matrix metalloproteases by substituted phenethyl compounds
11/20/1997	WO1997043245A1 Inhibition of matrix metalloproteases by acetylene containing compounds
11/20/1997	WO1997043240A1 INHIBITION OF MATRIX METALLOPROTEASES BY 2-(φ-AROYLALKYL)-4-BIARYL-OXOBUTYRIC ACIDS
11/20/1997	WO1997043239A1 Inhibition of matrix metalloproteases by 2-substituted-4-(4-substitutedphenyl)-4-oxobutyric acids
11/20/1997	WO1997043238A1 Substituted oxobutyric acids as matrix metalloprotease inhibitors
11/20/1997	WO1997043237A1 Subsitute 4-arylbutyric acid derivatives as matrix metalloprotease inhibitors
11/20/1997	WO1997042941A2 Buccal delivery system
11/20/1997	CA2253802A1 Benzofurans and benzopyrans as chronobiological agents
11/19/1997	EP0807633A2 Novel 2,3-disubstituted-(5,6)- heteroarylfused-pyrimidine-4-ones
11/19/1997	EP0807440A2 Chlorhexidine gluconate-containing stabilized aqueous pharmaceutical preparations
11/19/1997	EP0807111A1 Substituted heterocyclic compounds, preparation method therefor and pharmaceutical compositions containing same
11/19/1997	EP0806960A1 Extracts of shark cartilage, process of production and uses thereof
11/19/1997	EP0806954A1 Inhibition of the degradation of connective tissue matrix protein components in mammals
11/19/1997	EP0806947A1 Formulations and methods for reducing skin irritation
11/19/1997	CN1165000A Method of reducing tissue damage associated with ischemia
11/18/1997	US5688968 Enantioselective synthesis of 5,6-dihydro-(S)-4-(ethylamino)-(S)-6-methyl-4H-thieno 2,3-B!thiopyran-2-sulfonamide 7,7-dioxide
11/18/1997	US5688957 (3"-thioxacyclohex-1"-enyl)!-but-3'-ene-1'-ynyl!aryl and (3"-thioxacyclohex-1"-enyl)!-but-3'-ene-1'-ynyl!heteroaryl carboxylic acids and esters having retinoid-like biological activity
11/18/1997	US5688825 Sulfonyloxysuccimides
11/18/1997	US5688818 Enzyme inhibitors
11/18/1997	US5688817 Di(aromatic) compounds and their use in human and veterinary medicine and in cosmetics
11/18/1997	US5688765 Dry eyes
11/18/1997	US5688532 Aqueous solution of zinc chloride or zinc sulfate, treatment of hay fever and asthma
11/18/1997	CA2122360C Quinazolinone antianginal agents
11/13/1997	WO1997042337A1 Gene expression in monocytes and macrophages
11/13/1997	WO1997042187A1 Oxindole derivatives
11/13/1997	WO1997041899A1 New medicaments containing gelatin cross-linked with oxidized polysaccharides
11/13/1997	WO1997041830A1 Reparation and prevention of fibrotic lesions
11/13/1997	WO1997041824A2 Antiangiogenic peptides derived from plasminogen

1 ... 473 474 475 476 477 478 479 480 481 482 483 484 485 486 487 488 489 490 491 492 493 ... 531